RSSCategory: Biotechnology

Precision Medicine: The promise vs. the reality

Precision Medicine: The promise vs. the reality

Scientists find great potential in using genetic sequencing to help direct targeted cancer therapy, but practicing oncologists see some important limitations.

June 26, 2017 | By | Reply More
How two common medications became one $455 million specialty pill

How two common medications became one $455 million specialty pill

Vimovo was created using two readily and cheaply available generic, or over-the-counter, medicines: naproxen, also known by the brand Aleve, and esomeprazole magnesium, also known as Nexium.

June 22, 2017 | By | Reply More
Bodybuilding products can be risky, FDA warns

Bodybuilding products can be risky, FDA warns

Bodybuilding products that contain steroids or steroid-like substances are associated with potentially serious health risks, including life-threatening reactions such as kidney damage, heart attack, and stroke.

June 20, 2017 | By | Reply More
Interactive medical drones: No longer science fiction

Interactive medical drones: No longer science fiction

By combining the two technologies, drones and telemedicine, a medical supplies could be flown into a disaster area and doctor miles away could instruct a layman at the scene in how to provide rudimentary, but perhaps life-saving, medical care.

June 16, 2017 | By | Reply More
Tom Price bought drug stocks. Then he pushed pharma’s agenda in Australia.

Tom Price bought drug stocks. Then he pushed pharma’s agenda in Australia.

Price’s lobbying abroad is another example of how his work in Congress could have benefitted his investment portfolio. He traded hundreds of thousands of dollars’ worth of shares in health-related companies while taking action on legislation and regulations affecting the industry.

June 1, 2017 | By | Reply More
Stem cells show promise – but they also have a darker side

Stem cells show promise – but they also have a darker side

While some types of stem cells are already being used in treatment – for treating diseases of the blood and leukaemia, for example, multiple sclerosis and problems in the bone, skin and eye – there’s still a lot of hype and exaggeration, with some even selling empty promises to seriously ill or injured patients.

May 28, 2017 | By | Reply More
A spoonful of kid’s medicine makes the profits go up

A spoonful of kid’s medicine makes the profits go up

Laws designed to encourage companies to do more in terms of testing and developing medicines for children are allowing companies retain the market for theres drugs without facing competition for a longer period of time. As a result, the treatments cost a lot more.

April 24, 2017 | By | Reply More
Drugmakers help turn patients with rare diseases into D.C. lobbyists

Drugmakers help turn patients with rare diseases into D.C. lobbyists

National polls identify high drug prices as Americans’ No. 1 health care complaint. But these behind-the-scenes partnerships between the pharmaceutical industry and rare disease advocacy groups may work against lowering the price of high-price drugs.

April 12, 2017 | By | Reply More
Enzymes versus nerve agents: Designing antidotes for chemical weapons

Enzymes versus nerve agents: Designing antidotes for chemical weapons

Researchers in the U.S. and around the world, including here at the University of Washington’s Institute for Protein Design, are developing the tools needed to quickly and safely destroy nerve agents – both in storage facilities and in the human body.

April 11, 2017 | By | Reply More
Tracking air quality block by block

Tracking air quality block by block

A local environmental advocacy group last week launched a first-of-its kind monitoring project, installing air quality sensors in the densely packed neighborhoods near this city’s port to give the people who live and work there on-the-ground readings of pollutants that can seriously injure their health.

April 11, 2017 | By | Reply More